Time to embrace access programmes for medicines lessons from the South African flucytosine access programme

dc.citation.doi10.1016/J.IJID.2020.02.057
dc.citation.epage461
dc.citation.spage459
dc.contributor.authorA Shroufi
dc.contributor.authorNelesh Govender
dc.contributor.authorG Meintjes
dc.contributor.authorJohn Black
dc.contributor.authorJeremy Nel
dc.contributor.authorM Moosa
dc.contributor.authorColin Menezes
dc.contributor.authorE et al
dc.date.accessioned2023-07-03T09:36:20Z
dc.date.available2023-07-03T09:36:20Z
dc.departmentNational Institute for Communicable Diseases (NICD)
dc.identifier.citationWOS
dc.identifier.issn1201-9712
dc.identifier.urihttps://hdl.handle.net/10539/35629
dc.journal.titleINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
dc.journal.volume95
dc.titleTime to embrace access programmes for medicines lessons from the South African flucytosine access programme
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal.pdf
Size:
1.83 MB
Format:
Adobe Portable Document Format
Description:
Journal